Shanghai, China

Xiaoxuan Yan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaoxuan Yan. Retrieved from https://idiyas.com/inventor/xiaoxuan-yan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaoxuan Yan in Pharmaceutical Development

Introduction

Xiaoxuan Yan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on fused ring derivatives.

Latest Patents

Xiaoxuan Yan holds 1 patent for his invention titled "Fused ring derivatives containing 1,4-oxazepane." This patent relates to a series of fused ring derivatives and a preparation method for these compounds. Specifically, it focuses on a compound as shown in formula (II) and its pharmaceutically acceptable salts.

Career Highlights

Xiaoxuan Yan is currently employed at Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. His work at this esteemed company has allowed him to explore and develop innovative pharmaceutical solutions.

Collaborations

He collaborates with talented coworkers, including Lele Zhao and Deheng Chen, who contribute to the dynamic research environment at their workplace.

Conclusion

Xiaoxuan Yan's contributions to pharmaceutical innovations, particularly through his patented work, highlight his role as a key inventor in the industry. His ongoing efforts continue to advance the field of pharmaceutical development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…